(Q47980067)

7 February 2018

title

Murine double-minute 2 homolog single nucleotide polymorphism 309 and the risk of gynecologic cancer. (English)

1 reference

7 February 2018

single-nucleotide polymorphism

main subject

1 reference

4

Eisaku Toji

1 reference

7 February 2018

Kiyo Torii

8

object named as

Kiyo Torii

1 reference

7 February 2018

Sadamu Noda

9

object named as

Sadamu Noda

1 reference

7 February 2018

Shinji Izuma

6

object named as

Shinji Izuma

1 reference

7 February 2018

author name string

Masatsugu Ueda

1

1 reference

7 February 2018

Michiko Yamamoto

2

1 reference

7 February 2018

Osamu Nunobiki

3

1 reference

7 February 2018

Naomi Sato

5

1 reference

7 February 2018

Yoshiaki Okamoto

7

1 reference

7 February 2018

publication date

1 May 2009

1 reference

7 February 2018

published in

Human Cell

1 reference

7 February 2018

volume

22

1 reference

7 February 2018

issue

2

1 reference

7 February 2018

page(s)

49-54

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1111/j.1749-0774.2009.00068.x

exact match

0 references

cites work

mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2009.00068.X

Regulation of p53 function

21 January 2018

1 reference

12 December 2020

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis

1 reference

12 December 2020

Both germ line and somatic genetics of the p53 pathway affect ovarian cancer incidence and survival

1 reference

12 December 2020

Genetic association studies in digestive system malignancies.

1 reference

12 December 2020

p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

1 reference

12 December 2020

MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner

1 reference

12 December 2020

Involvement of p53 gene mutations in human endometrial carcinomas

1 reference

12 December 2020

p53 overexpression and mutation in endometrial carcinoma: inverted relation with estrogen and progesterone receptor status

1 reference

12 December 2020

Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk.

1 reference

12 December 2020

Regulation of p53 stability by Mdm2

1 reference

12 December 2020

Common polymorphisms in TP53 and MDM2 and the relationship to TP53 mutations and clinical outcomes in women with ovarian and peritoneal carcinomas

1 reference

12 December 2020

Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas

1 reference

12 December 2020

MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.

1 reference

12 December 2020

Germline polymorphism of p53 codon 72 in gynecological cancer.

1 reference

12 December 2020

Germline polymorphism of cancer susceptibility genes in gynecologic cancer

1 reference

12 December 2020

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

1 reference

12 December 2020

Mutation and allelic loss of the p53 gene in endometrial carcinoma. Incidence and outcome in 92 surgical patients

1 reference

12 December 2020

MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population

1 reference

12 December 2020

No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer.

1 reference

12 December 2020

Glutathione S-transferase GSTM1, GSTT1 and p53 codon 72 polymorphisms in human tumor cells

1 reference

12 December 2020

MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapy

1 reference

12 December 2020

Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification

1 reference

12 December 2020

No association between SNP309 promoter polymorphism in the MDM2 and cervical cancer in a study from northeastern Brazil

1 reference

12 December 2020

Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status.

1 reference

12 December 2020

MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C

1 reference

12 December 2020

MDM2 SNP309 is associated with endometrial cancer risk

1 reference

12 December 2020

10.1111/J.1749-0774.2009.00068.X

Identifiers

DOI

1 reference

7 February 2018

Dimensions Publication ID

0 references

1 reference

7 February 2018